643.3500 -8.55 (-1.31%)
NSE Jul 31, 2025 15:05 PM
Volume: 78,580
 

643.35
-1.31%
Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Solara Active Pharma Sciences Ltd. has gained 25.43% in the last 3 Months
More from Solara Active Pharma Sciences Ltd.
Recommended